Patient Education - Teva supports organizations that educate people with Huntington’s disease, tardive dyskinesia, or schizophrenia and their caregivers to improve understanding of symptoms, management, and treatment.
Tardive Dyskinesia - HCP supports healthcare professionals through independent medical education to improve recognition, diagnosis, assessment, and management of TD, including VMAT2 inhibitor use.
HCP Education - Teva supports healthcare professionals, patients, and caregivers through independent education to strengthen clinical decisions and improve health behaviors or health status.
Schizophrenia – HCP supports educational providers delivering independent healthcare professional education on antipsychotics and long-acting injectables to improve treatment competence and prevent relapse.
Tourette Association of America funds interdisciplinary consortia and collaborative research projects to address major scientific challenges in Tourette Syndrome.